Neha Sudol, MD
NPI 1891055075 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Anaheim, CA
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1891055075
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense A141471 (CA)
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
14 yrs in NPPES registry
- Profile completeness33% of score
83% of core fields populated
- Practice footprint20% of score
2 documented practice locations
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 186 | 125 |
| Mirabegronbrand: Myrbetriq | 122 | 59 |
| Trospium Chloride | 80 | 38 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 59 | 44 |
| Mirabegronbrand: Mirabegron Er | 56 | 45 |
| Cephalexin | 53 | 31 |
| Nitrofurantoin Macrocrystalbrand: Nitrofurantoin | 28 | 15 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,516 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 333 the City Drive WestSuite 1400Orange, CA 92868Phone: (714) 456-6807Fax: (714) 456-7754
Registry dates
- Enumerated
- 2012-05-22
- Last updated
- 2022-01-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.